Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Ucello Therapeutics logo — company profile

Ucello Therapeutics

Founded 2020 Series A Total: $275.00M Biotechnology, Pharmaceutical

General Information

Company Name Ucello Therapeutics
Founded Year 2020
Industries Biotechnology, Pharmaceutical
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Ucello Therapeutics. To contact Ucello Therapeutics, visit ucello.cn.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Ucello Therapeutics compare?

A PDF of Ucello Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Ucello Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Ucello Therapeutics

Ucello Therapeutics is a biotechnology and pharmaceutical startup that was founded in 2020. The company recently received a significant CNY150.00M Series A investment on 02 June 2023. The investors involved in this funding round include Cowin Venture, Matrix Partners China, InterChina Capital, Penglai Capital, Guosheng Group, and Juke Investment.

Ucello Therapeutics, with its focus on biotechnology and pharmaceuticals, has managed to attract a substantial investment from a diverse group of prominent investors. This latest funding round reflects strong investor confidence in the company's vision and potential within the industry.

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A CNY150.00M 6
Cowin Venture Matrix Partners China
Cowin Venture, Matrix Partners China +4
02 Jun 2023
Debt Financing CNY100.00M -
02 Jun 2023
Series A $25.00M 4
Northern Light Venture Capital Cowin Venture 成都天府国际生物城投资开发有限公司
Northern Light Venture Capital, Cowin Venture +2
10 Feb 2022

FAQ About Ucello Therapeutics

Ucello Therapeutics was founded in 2020.
Ucello Therapeutics operates in Biotechnology and Pharmaceutical.
Ucello Therapeutics has completed 3 funding rounds, raising a total of $275.00M. The latest funding stage is Series A.

We're actively collecting intelligence on Ucello Therapeutics.

Source: BounceWatch company record for Ucello Therapeutics, https://bouncewatch.com/company/ucello-therapeutics, updated 26 July 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout